Venture Capital

New York's Peripherii launches Priamble™, audio earrings blending luxury jewelry with open-ear tech. Is this the future of wearable sound for women?

A new deal links Mexico’s largest scouting academy with Spain's Cádiz CF, promising a direct route to European football for young talent.

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

HEYTEA's first global launch with POP MART's Twinkle Twinkle reveals a sophisticated strategy for world domination, one cup of new-style tea at a time.

The premier investor summit returns with a global tour, new sessions on real estate, and a renewed focus on funding critical pediatric cancer research.

The Department of War is funding a Montana firm to secure the U.S. supply chain for critical materials used in advanced thermal imaging and missile guidance.

Tired of ads and algorithms? Gistvox has launched an audio-only app with a radical idea: intentional listening. But can its unique business model survive?

A CETY affiliate moves its 2.2 MW Vermont plant through regulatory hurdles, but past setbacks, new technology, and financial questions loom large.

With a new HQ and $2M in contracts, Taoping is leveraging AI and government policy to modernize China's aging elevators, but faces investor scrutiny.

Ultragenyx's stock plummets after its Osteogenesis Imperfecta drug fails to reduce fractures, a major blow for patients and a test of the firm's pipeline.

A new VR experience from Braindance uses a radical rendering method to make virtual worlds feel less like a game and more like a place you can truly occupy.

As its cash runway shortens, Longeveron's novel stem cell therapy gets a major boost with selection for a prestigious Alzheimer's health moonshot.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

The investment firm sheds its medical focus, adopting a new name and a broader mandate to chase cross-sector opportunities in the booming AI market.

With its 'Results Your Way' plan, the fitness giant is rolling out personalized coaching, recovery zones, and Pilates to compete in a changing market.

Sofie Biosciences begins late-stage trials for a novel PET scan targeting aggressive gastrointestinal cancers, a breakthrough that could redefine detection.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.